GB201009097D0 - Compounds for the treatment of clostridium difficile-associated disease - Google Patents
Compounds for the treatment of clostridium difficile-associated diseaseInfo
- Publication number
- GB201009097D0 GB201009097D0 GBGB1009097.5A GB201009097A GB201009097D0 GB 201009097 D0 GB201009097 D0 GB 201009097D0 GB 201009097 A GB201009097 A GB 201009097A GB 201009097 D0 GB201009097 D0 GB 201009097D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- treatment
- associated disease
- clostridium difficile
- difficile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000193163 Clostridioides difficile Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009097.5A GB201009097D0 (en) | 2010-06-01 | 2010-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
BR112012030621-9A BR112012030621B1 (en) | 2010-06-01 | 2011-06-01 | compounds for the treatment of disease associated with clostridium difficile |
ES11728027.1T ES2568455T3 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of Clostridium difficile-associated disease |
RS20160310A RS54781B1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
CA2801274A CA2801274C (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
DK11728027.1T DK2575968T3 (en) | 2010-06-01 | 2011-06-01 | COMPOUNDS FOR THE TREATMENT OF Clostridium difficile-associated disease |
EP15190275.6A EP3011960B1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
PCT/GB2011/000831 WO2011151621A1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
PT117280271T PT2575968E (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
JP2013512984A JP5845502B2 (en) | 2010-06-01 | 2011-06-01 | Compounds for treating Clostridium difficile-related diseases |
AU2011260097A AU2011260097B2 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
PL11728027T PL2575968T3 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
ES15190275T ES2803556T3 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of diseases associated with clostridium difficile |
SI201130790A SI2575968T1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
RU2012157571/04A RU2575477C2 (en) | 2010-06-01 | 2011-06-01 | Compounds for treating clostridium difficile associated diseases |
EP11728027.1A EP2575968B1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
CN201180037073.2A CN103025383B (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
HUE11728027A HUE028746T2 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
US13/691,319 US8987308B2 (en) | 2010-06-01 | 2012-11-30 | Compounds for the treatment of Clostridium difficile-associated disease |
HK13104684.8A HK1177706A1 (en) | 2010-06-01 | 2013-04-17 | Compounds for the treatment of clostridium difficile associated disease |
HK16111340.6A HK1223032A1 (en) | 2010-06-01 | 2013-04-17 | Compounds for the treatment of clostridium difficile associated disease |
US14/620,902 US9278091B2 (en) | 2010-06-01 | 2015-02-12 | Compounds for the treatment of Clostridium difficile associated disease |
JP2015090826A JP6150841B2 (en) | 2010-06-01 | 2015-04-27 | Compounds for treating Clostridium difficile-related diseases |
US15/011,185 US20170217983A2 (en) | 2010-06-01 | 2016-01-29 | Compounds for the treatment of clostridium difficile associated disease |
HRP20160397TT HRP20160397T1 (en) | 2010-06-01 | 2016-04-18 | Compounds for the treatment of clostridium difficile associated disease |
CY20161100379T CY1117671T1 (en) | 2010-06-01 | 2016-05-06 | CLOSTRIDIUM DIFFICILE COMPLICATIONS FOR THERAPEUTIC DISEASE TREATMENT |
SM201600260T SMT201600260B (en) | 2010-06-01 | 2016-08-03 | COMPOUNDS FOR TREATING A DISEASE ASSOCIATED WITH A DIFFICULT CLOSTRIDIUM |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009097.5A GB201009097D0 (en) | 2010-06-01 | 2010-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201009097D0 true GB201009097D0 (en) | 2010-07-14 |
Family
ID=42371262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1009097.5A Ceased GB201009097D0 (en) | 2010-06-01 | 2010-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201009097D0 (en) |
-
2010
- 2010-06-01 GB GBGB1009097.5A patent/GB201009097D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201403795B (en) | Formulations for the treatment of diabetes | |
EP2558493A4 (en) | Antibodies for the treatment of clostridium difficile-associated infection and disease | |
HRP20160397T1 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
EP2654745A4 (en) | Composition for the treatment of skin conditions | |
EP2621498A4 (en) | Combination treatment for dermatological conditions | |
SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
EP2521569A4 (en) | Combined treatment utilizing vb-201 | |
PL2548439T3 (en) | Plant disease control agent | |
SI2605764T1 (en) | Compositions for the treatment of cancer | |
IL222479A (en) | Methods for tissue engineering | |
EP2544686A4 (en) | Combination methods for treatment of disease | |
EP2536436A4 (en) | Antimir-451 for the treatment of polycythemias | |
EP2582410A4 (en) | Methods for complex tissue engineering | |
EP2556161A4 (en) | Methods for the treatment of autoimmune diseases | |
EP2601954A4 (en) | Therapeutic agent for disease | |
GB201013060D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009091D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201013058D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009108D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009090D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009085D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009097D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201009095D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201106972D0 (en) | Compounds for the treatment of clostridium difficile-associated disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |